Treatment with parathyroid peptides and estrogen replacement for severe postmenopausal vertebral osteoporosis: prediction of long-term responses in spine and femur.
Fifteen women with severe vertebral osteoporosis were treated with daily parathyroid peptide (hPTH) plus hormone-replacement co-therapy (HRT) for 1 year. Eight other patients were randomized to HRT alone. Co-therapy with hPTH and HRT resulted in an impressive mean treatment response at the spine (du...
Հիմնական հեղինակներ: | Reeve, J, Mitchell, A, Tellez, M, Hulme, P, Green, JR, Wardley-Smith, B, Mitchell, R |
---|---|
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
2001
|
Նմանատիպ նյութեր
-
Human parathyroid peptide treatment of vertebral osteoporosis.
: Reeve, J, և այլն
Հրապարակվել է: (1993) -
Periodic courses of human 1-34 parathyroid peptide alternating with calcitriol paradoxically reduce bone remodelling in spinal osteoporosis.
: Reeve, J, և այլն
Հրապարակվել է: (1987) -
A short-cycle ADFR regimen using parathyroid peptide hPTH 1–34 in idiopathic osteoporosis
: Reeve, J, և այլն
Հրապարակվել է: (1986) -
Gastrointestinal calcium absorption and dietary calcium load: relationships with bone remodelling in vertebral osteoporosis.
: Tellez, M, և այլն
Հրապարակվել է: (1995) -
Does the presence of postmenopausal symptoms influence susceptibility to vertebral deformity? European Vertebral Osteoporosis Study (EVOS) Group.
: Scoutellas, V, և այլն
Հրապարակվել է: (1999)